• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    FDA Has Accepted the New Drug Application (NDA) for Ensartinib

    BUSINESSWIRE

    Ensartinib Secured Its First Approval for 1st Line Treatment in ALK+ NSCLC

    BUSINESSWIRE

    Takeda offers value-based pricing for Alunbrig

    FIERCEPHARMA

    Vanderbilt Oncologists Publish Results of First Study

    BUSINESSWIRE

    The Lancet Respiratory Medicine Published Study Shows Ensartinib

    BIOSPACE

    The Lancet Respiratory Medicine Published Study of Ensartinib

    BUSINESSWIRE

    Xcovery Announces Initiation of Phase 2 Clinical Trial for Ensartinib

    ABCNEWS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.